Description

+ Include: 50 videos, size: 3.86 GB

+ Target Audience: cardiologist, primary care physician, internists

+ Sample video: contact me for sample video

+ Information:

Topics include:Essentials of cardiovascular disease, structural heart disease, ischemia, aortic stenosis, tricuspid regurgitation, hypertrophic cardiomyopathy, heart failure, atrial fibrillation, syncope, statins, dietary impact, pharmacotherapy, hypertension, special populations, hormone therapy, rehab, peripheral artery disease,  pacemakers, wearables and much more!

The Meetings By Mail Cleveland Clinic Cardiovascular Update 2025 is designed for healthcare professionals involved in cardiovascular care. This includes:

• General Cardiologists: To stay updated on the latest advancements in cardiovascular disease prevention and management.
• Primary Care Providers: For insights into managing cardiovascular risks in diverse patient populations.
• Internal Medicine Specialists: To enhance their understanding of cardiovascular conditions and treatments.
• Nurse Practitioners and Physician Assistants: Focused on improving patient outcomes in cardiovascular care.
• Residents and Fellows: Seeking to deepen their knowledge in cardiology.
• Pharmacists and Nurses: Interested in the latest evidence-based practices for cardiovascular health.

This program emphasizes cutting-edge advances, evidence-based guidelines, and promoting health equity among diverse populations.

 

+ Topics:

1 Tools in CVD Prevention and Risk Management To Test or Not to Test Lp(a),apoB, Non HDL-C.mp4

2 Statin Initiation for Primary Prevention Among Statin Na‹ve Adults and Reasons for Nonadherence.mp4

3 When Statins Are Not Enough – Non-statin Lipid Lowering Therapies to Manage Residual Risk.mp4

4 Managing Anti-Hyperglycemic and CV Risk Reduction Agents in Patients With Diabetes SGLT2i or GLP1RA or Both.mp4

5 Weight Loss Pharmacotherapy Utilizing Current Therapies and Exploring the Next Generation of Weight Loss Medications.mp4

6 Keto, Low Carb, Plant Based, IF Controversies in the Evidence for the “Best “Diet What is the Evidence and How to Apply in Clinical Practice.mp4

7 Old and Evolving Strategies for Treatment-Resistant Hypertension.mp4

8 Social Determinants of Health and Cardiovascular Disease Current State and Future Directions.mp4

9 Panel DiscussionQ&A.mp4

10 Hormone Therapy and Heart Health Debunking Myths, Embracing Evidence.mp4

11 The Intersection of Cardiovascular Disease and Chronic Kidney Disease Strategies for Reducing Cardiovascular Risk.mp4

12 Who Should Get a CAC How Often How to Use the Results to Assess Risk.mp4

13 Management of CV Issues in the Elderly Geriatric Cardiology.mp4

14 Population Health Management Interventions to Control Cardiovascular Disease Risk Factors Current Status.mp4

15 Panel DiscussionQ&A.mp4

16 Cardiac Disease Remains the Leading Cause of Mortality in Women What are we Doing to Address This.mp4

17 Cardiovascular Disease and Pregnancy Optimizing Maternal and Fetal Health.mp4

18 Competitive Sports Participation in Athletes with Heart Disease Evaluation and Management.mp4

19 Cardio-oncology Optimizing the Balance Between Cancer Outcomes and Cardiac Success.mp4

20 Panel DiscussionQ&A.mp4

21 Role of Advanced Imaging for Ischemic Heart Disease CT, CMR, Nuclear and Advanced Echocardiography.mp4

22 Creating a Pathway for the Management of Stable Angina in Your Clinic Structured Risk Assessment and Clinical Decision Making.mp4

23 ANOCA, INOCA, MINOCA What Does It All Mean Diagnostic Testing and Therapeutic Management.mp4

24 How Do I Manage my Post MI Patient (Including DAPT GuidelinesDurationCardiacRehab).mp4

25 Cardiac Rehab Why it is Critical and How Can We Improve Access and Compliance.mp4

26 Peripheral Artery Disease Assessment and Clinical Decision Making.mp4

27 Panel DiscussionQ&A.mp4

28 Aortic Stenosis Diagnosis and Management in the Modern Era.mp4

29 MR How to Diagnose and Manage Mitral Valve Disease When to Refer What are the Options.mp4

30 What to Know About the Natural History of Tricuspid Regurgitation Current and Future Management Strategies.mp4

31 Bicuspid and Aneurysm-Associated Aortic Valve Disease Timing of Intervention and the Role of Family Screening.mp4

32 Guidelines for Anticoagulation Following Structural Heart Therapies.mp4

33 Hypertrophic Cardiomyopathy Co-management in the Era of Emerging Precision Therapies.mp4

34 Panel DiscussionQ&A.mp4

35 Heart Failure Stages, Phenotypes and Diagnosis and How to Screen for HF in the Primary Care Setting.mp4

36 HFrEF Essentials of Guideline Directed Medical Therapy Initiation and Titration.mp4

37 Managing Comorbidities in HF Frailty, Anemia, Sleep Apnea, AF, Obesity.mp4

38 Essentials of Diagnosis and Management for HFpEF.mp4

39 Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM).mp4

40 Strategies to Enhance GDMT Implementation and Adherence.mp4

41 Managing Long Term LVADs and Transplant Recipients in the Community Setting.mp4

42 The Importance of Collaboration Between EP and HF CRT and Novel Pacing.mp4

43 Panel DiscussionQ&A.mp4

44 Diagnosis and Management of New-Onset Atrial Fibrillation.mp4

45 AF and Left Atrial Appendage Closure Current and Future Directions.mp4

46 What I Need to Know to Evaluate and Manage the Patient With PVCs and SVT.mp4

47 Evaluation and Management of Syncope in the Young Adult.mp4

48 Follow-Up of Pacemakers and ICDs For the Non-Electrophysiologist.mp4

49 Wearables for Arrhythmia Care Current Challenges and Future Prospects.mp4

50 Panel DiscussionQ&A.mp4